These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2152501)

  • 1. Afferent lymph dendritic cells: a model for antigen capture and presentation in vivo.
    Bujdoso R; Harkiss G; Hopkins J; McConnell I
    Int Rev Immunol; 1990; 6(2-3):177-86. PubMed ID: 2152501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo modulation of CD1 and MHC class II expression by sheep afferent lymph dendritic cells. Comparison of primary and secondary immune responses.
    Hopkins J; Dutia BM; Bujdoso R; McConnell I
    J Exp Med; 1989 Oct; 170(4):1303-18. PubMed ID: 2477489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fc gamma receptor expression on sheep afferent lymph dendritic cells and rapid modulation of cell surface phenotype following Fc gamma receptor engagement in vitro and in vivo.
    Coughlan SN; Harkiss GD; Dickson L; Hopkins J
    Scand J Immunol; 1996 Jan; 43(1):31-8. PubMed ID: 8560194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced proliferation of CD4+ T cells induced by dendritic cells following antigen uptake in the presence of specific antibody.
    Coughlan S; Harkiss GD; Hopkins J
    Vet Immunol Immunopathol; 1996 Jan; 49(4):321-30. PubMed ID: 8677634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage.
    Bujdoso R; Hopkins J; Dutia BM; Young P; McConnell I
    J Exp Med; 1989 Oct; 170(4):1285-301. PubMed ID: 2794860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The survival and growth of ovine afferent lymph dendritic cells in culture depends on tumour necrosis factor-alpha and is enhanced by granulocyte-macrophage colony-stimulating factor but inhibited by interferon-gamma.
    Haig DM; Percival A; Mitchell J; Green I; Sargan D
    Vet Immunol Immunopathol; 1995 Apr; 45(3-4):221-36. PubMed ID: 7545851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.
    de Jong JM; Schuurhuis DH; Ioan-Facsinay A; Welling MM; Camps MG; van der Voort EI; Huizinga TW; Ossendorp F; Verbeek JS; Toes RE
    Immunology; 2006 Dec; 119(4):499-506. PubMed ID: 16995881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel recycling mechanism of native IgE-antigen complexes in human B cells facilitates transfer of antigen to dendritic cells for antigen presentation.
    Engeroff P; Fellmann M; Yerly D; Bachmann MF; Vogel M
    J Allergy Clin Immunol; 2018 Aug; 142(2):557-568.e6. PubMed ID: 29074459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small number of anti-CD3 molecules on dendritic cells stimulate DNA synthesis in mouse T lymphocytes.
    Romani N; Inaba K; Puré E; Crowley M; Witmer-Pack M; Steinman RM
    J Exp Med; 1989 Mar; 169(3):1153-68. PubMed ID: 2522496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
    Adams EW; Ratner DM; Seeberger PH; Hacohen N
    Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro.
    Zhong G; Reis e Sousa C; Germain RN
    J Exp Med; 1997 Aug; 186(5):673-82. PubMed ID: 9271583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses.
    Bhardwaj N; Young JW; Nisanian AJ; Baggers J; Steinman RM
    J Exp Med; 1993 Aug; 178(2):633-42. PubMed ID: 8340760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
    Sallusto F; Lanzavecchia A
    J Exp Med; 1994 Apr; 179(4):1109-18. PubMed ID: 8145033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells as antigen presenting cells in vivo.
    Inaba K; Metlay JP; Crowley MT; Witmer-Pack M; Steinman RM
    Int Rev Immunol; 1990; 6(2-3):197-206. PubMed ID: 2152503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of antigen by afferent lymph dendritic cells mediated by antibody.
    Harkiss GD; Hopkins J; McConnell I
    Eur J Immunol; 1990 Nov; 20(11):2367-73. PubMed ID: 1701390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abundant empty class II MHC molecules on the surface of immature dendritic cells.
    Santambrogio L; Sato AK; Fischer FR; Dorf ME; Stern LJ
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15050-5. PubMed ID: 10611336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation and T cell stimulation by dendritic cells.
    Guermonprez P; Valladeau J; Zitvogel L; Théry C; Amigorena S
    Annu Rev Immunol; 2002; 20():621-67. PubMed ID: 11861614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling features of the natural MHC class II peptidome of skin-migrated dendritic cells.
    Muixí L; Contreras V; Collado JA; Alexandre Y; Ballingall K; Bonneau M; Jaraquemada D; Schwartz-Cornil I
    Int Immunol; 2012 Jan; 24(1):59-69. PubMed ID: 22194283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.